August 11, 2020 Necrotizing Enterocolitis: Using Regulatory Science and Drug Development to Improve Outcomes , September 2019
June 24, 2020 Watch now: Shortening the Timeline for Developing New Treatments – How the Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP) Can Help Webinar Join C-Path, the National Organization for Rare Disorders and the FDA for a free 1-hour webinar on the Rare Disease Cures Accelera
June 20, 2020 C-Path’s Transplant Therapeutics Consortium Receives Acceptance of Letter of Intent for iBox Scoring System (Composite Biomarker Panel) as a Reasonably Likely Surrogate Endpoint Biomarker aims to streamline the development of novel therapies intended to improve long-term outcomes for kidney transplan
June 19, 2020 Method of Blood Pressure Measurement in Neonates and Infants: A Systematic Review and Analysis
June 14, 2020 Standardized Data Structures in Rare Diseases: CDISC User Guides for Duchenne Muscular Dystrophy and Huntington’s Disease
June 12, 2020-June 18, 2020 The Rare Disease Clinical Outcome Assessment Consortium: Aiming to Fulfill Unmet Drug Development Endpoint Measurement Needs Presented at the DIA Virtual Global Annual Meeting, held June 12 – 18, 2020.
June 5, 2020 Watch now: What You Need to Know About the Rare Disease Cures Accelerator-Data and Analytics Platform Webinar Join C-Path, the National Organization for Rare Disorders and the FDA for a free 1-hour webinar on the Rare Disease Cures Accelera
